A feedforward-feedback glucose control strategy for type 1 diabetes mellitus

Journal of Process Control

Volumn 18, Issue 2, 2008, Pages 149-162

  Marchetti, Gianni ^a   Barolo, Massimiliano ^a   Jovanovič, Lois ^b   Zisser, Howard ^b   Seborg, Dale E ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c University of California   (United States)

Author keywords

Control; Diabetes; Glucose

Indexed keywords

COMPUTER SIMULATION; DRUG DELIVERY; FEEDBACK CONTROL; GLUCOSE; INSULIN; PHYSIOLOGICAL MODELS;

DIABETES MELLITUS; INSULIN BOLUS; PRE-PRANDIAL SNACK;

MEDICAL PROBLEMS;

EID: 38849140223     PISSN: 09591524     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprocont.2007.07.008     Document Type: Article

References (49)

1. Centers for Disease Control and Prevention, National diabetes fact sheet, (Atlanta, GA) (2005).
2. Gerich J.E. The importance of tight glycemic control. Am. J. Med. 118 9A (2005) 7-11. http://dx.doi.org/10.1016/j.amjmed.2005.07.051
3. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 3 (2003) 917-932
4. Diabetes Control and Complications Trials Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993) 977-986.
5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N. Engl. J. Med. 353 (2005) 2643-2653.
6. Hovorka R. Management of diabetes using adaptive control. Int. J. Adapt. Control Signal Process. 19 5 (2005) 309-325. http://dx.doi.org/10.1002/acs.851
7. Bellazzi R., Nucci G., and Cobelli C. The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng. Med. Biol. Mag. 20 1 (2001) 54-64. http://dx.doi.org/10.1109/51.897828
8. Parker R.S., Doyle III F.J., and Peppas N.A. The intravenous route to blood glucose control. IEEE Eng. Med. Biol. Mag. 20 1 (2001) 65-73
9. Steil G.M., Panteleon A.E., and Rebrin K. Closed-loop insulin delivery - the path to physiological glucose control. Adv. Drug Deliv. Rev. 56 2 (2004) 125-144. http://dx.doi.org/10.1016/j.addr.2003.08.011
10. Steil G.M., and Rebrin K. Closed-loop insulin delivery - what lies between where we are and where we are going. Expert Opin. Drug Deliv. 2 2 (2005) 353-362. http://dx.doi.org/10.1517/17425247.2.2.353
11. Bequette B.W. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol. Ther. 7 1 (2005) 28-47. http://www.liebertonline.com/doi/abs/10.1089/dia.2005.7.28
12. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet. Med. 23 (2006) 1-12. http://dx.doi.org/10.1111/j.1464-5491.2005.01672.x
13. Bergman R.N., Bowden C.R., and Cobelli C. The minimal model approach to quantification of factors controlling glucose disposal in man. In: Cobelli C., and Bergman R.N. (Eds). Carbohydrate Metabolism (1981), John Wiley & Sons Ltd. 269-293 Ch. 13
14. Parker R.S., Doyle III F.J., and Peppas N.A. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans. Biomed. Eng. 46 2 (1999) 148-157
15. S.M. Lynch, B.W. Bequette, Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements, in: Proc. of the 2002 Amer. Control Conf., Anchorage, Alaska, May, 2002, pp. 4039-4043.
16. Hovorka R., Chassin L.J., Wilinska M.E., Canonico V., Akwi J.A., Federici M.O., Massi-Benedetti M., Hutzli I., Zaugg C., Kaufmann H., Both M., Vering T., Schaller H.C., Schaupp L., Bodenlenz M., and Pieber T.R. Closing the loop: the ADICOL experience. Diabetes Technol. Ther. 6 3 (2004) 307-318. http://dx.doi.org/10.1089/152091504774197990
17. Schaller H.C., Schaupp L., Bodenlenz M., Wilinska M.E., Chassin L.J., Wach P., Vering T., Hovarka R.., and Pieber T.R. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with type 1 diabetes. Diabetic Med. 23 1 (2006) 90-93
18. Candas B., and Radziuk J. An adaptive plasma glucose controller based on a nonlinear insulin/glucose model. IEEE Trans. Biomed. Eng. 41 2 (1994) 116-124
19. Ibbini M., Masadeh M., and Amer M.M.B. A semiclosed-loop optimal control system for blood glucose level in diabetics. J. Med. Eng. Technol. 28 5 (2004) 189-196. http://dx.doi.org/10.1080/03091900410001662332
20. Trajanoski Z., and Wach P. Neural predictive controller for insulin delivery using the subcutaneous route. IEEE Trans. Biomed. Eng. 45 9 (1998) 1122-1134
21. Trajanoski Z., Regittnig W., and Wach P. Simulation studies on neural predictive control of glucose using the subcutaneous route. Comput. Meth. Programs Biomed. 56 2 (1998) 133-139
22. ∞ glucose control in diabetes using a physiological model. AIChE J. 46 12 (2000) 2537-2549
23. ∞ problem. Contr. Eng. Pract. 12 9 (2004) 1179-1195. http://dx.doi.org/10.1016/j.conengprac.2003.12.004
24. Hovorka R., Canonico V., Chassin L.J., Haueter U., Massi-Benedetti M., Federici M.O., Pieber T.R., Schaller H.C., Schaupp L., Vering T., and Wilinska M.E. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol. Meas. 25 4 (2004) 905-920. http://dx.doi.org/10.1088/0967-3334/25/4/010
25. Zisser H., Jovanovič L., Doyle III F., Ospina P., and Owens C. Run-to-run control of meal-related insulin dosing. Diabetes Technol. Ther. 7 1 (2005) 48-57. http://www.liebertonline.com/doi/abs/10.1089/dia.2005.7.48
26. C.C. Palerm, H. Zisser, L. Jovanovič, F.J. Doyle III, Flexible run-to-run strategy for insulin dosing in type 1 diabetic subjects, in: Proc. of the IFAC International Symposium on Advanced Control of Chemical Processes (ADCHEM), Gramado, Brazil, 2006, pp. 521-526.
27. Chassin L.J., Wilinska M.E., and Hovorka R. Grading system to assess clinical performance of closed-loop glucose control. Diabetes Technol. Ther. 7 1 (2005) 72-82. http://dx.doi.org/10.1089/dia.2005.7.72
28. G. Marchetti, M. Barolo, L. Jovanovic, H. Zisser, D.E. Seborg, An improved PID switching control strategy for type 1 diabetes, IEEE Trans. Biomedical Eng., in press.
29. G. Marchetti, Improved glucose control strategies for subjects with type 1 diabetes mellitus, Graduation Thesis in Chemical Engineering, Department of Chemical Engineering Priciples and Practice, University of Padova, Italy, 2006.
30. Cobelli C., Nucci G., and Del Prato S. A physiological simulation model of the glucose-insulin system in type I diabetes. Diabetes Nutr. Metab. 11 1 (1998) 78
31. Bergman R.N. The minimal model: yesterday, today, and tomorrow. In: Bergman R.N., and Lovejoy J.C. (Eds). The minimal model approach and determinants of glucose tolerance. Pennington Center Nutrition Series Vol. 7 (1997), Louisiana State University Press, Baton Rouge, LA 3-50
32. Makroglou A., Li J., and Kuang Y. Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview. Appl. Num. Math. 56 3-4 (2006) 559-573. http://dx.doi.org/10.1016/j.apnum.2005.04.023
33. Wilinska M.E., Chassin L.J., Schaller H.C., Schaupp L., Pieber T.R., and Hovorka R. Insulin kinetics in type-1 diabetes: Continuous and bolus delivery of rapid acting insulin. IEEE Trans. Biomed. Eng. 52 1 (2005) 3-12. http://dx.doi.org/10.1109/TBME.2004.839639
34. Dalla Man C., Camilleri M., and Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans. Biomed. Eng. 53 12 Pt 1 (2006) 2472-2478
35. Hovorka R., Shojaee-Moradie F., Carroll P.V., Chassin L.J., Gowrie I.J., Jackson N.C., Tudor R.S., Umpleby A.M., and Jones R.H. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am. J. Physiol. Endocrinol. Metab. 282 5 (2002) E992-E1007. http://dx.doi.org/10.1152/ajpendo.00304.2001
36. D.A. Finan, H. Zisser, L. Jovanovič, W. Bevier, D.E. Seborg, Identfication of linear dynamic models for type 1 diabetes: a simulation study, in: Proc. of the International Symposium on Advanced Control of Chemical Processes (ADCHEM), Gramado, Brazil, 2006, pp. 503-508.
37. Steil G., Rebrin K., Darwin C., Hariri F., and Saad M. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 55 12 (2006) 2244-3350
38. Steil G., and Saad M. Automated insulin delivery for type 1 diabetes. Diabetes and the endocrine pancreas. Curr. Opin. Endocrinol. & Diabetes 13 2 (2006) 205-211
39. Wintergerst K., Deiss D., Buckingham B., Cantwell M., Kache S., Agarwal s., Wilson D., and Steil G. Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. Diabetes Technol Ther 9 3 (2007) 211-222
40. Doran C.V., Chase J.G., Shaw G.M., Moorhead K.T., and Hudson N.H. Derivative weighted active insulin control algorithms and intensive care unit trials. Contr. Eng. Pract. 13 9 (2005) 1129-1137. http://dx.doi.org/10.1016/j.conengprac.2004.10.009
41. Lam Z.-H., Hwang K.-S., Lee J.-Y., Chase J.G., and Wake G.C. Active insulin infusion using optimal and derivative-weighted control. Med Eng Phys 24 10 (2002) 663-672. http://dx.doi.org/10.1016/S1350-4533(02)00147-9
42. Chee F., Fernando T.L., Savkin A.V., and van Heeden V. Expert PID control system for blood glucose control in critically ill patients. IEEE Trans. Inform. Technol. Biomed. 7 4 (2003) 419-425. http://dx.doi.org/10.1109/TITB.2003.821326
43. Dimitriadis G., and Gerich J. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6 4 (1983) 374-377
44. Jacobs M., Keulen E., Kanc K., Casteleijn S., Scheffer P., Deville W., and Heine R. Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. a comparison with human regular insulin during a three-meal test period. Diabetes Care 20 8 (1997) 1279-1286
45. Danne T., Aman J., Schober E., Deiss D., Jacobsen J.L., Friberg H.H., and Jensen L.H. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 26 8 (2003) 2359-2364. http://care.diabetesjournals.org/cgi/content/abstract/26/8/2359
46. Carr K., Idama T., Masson E., Ellis K., and Lindow S. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes-the effect on glycaemic excursion. J. Obstet. Gynaecol. 24 4 (2004) 382-386
47. Jovanovič L., Giammattei J., Acquistapace M., Bornstein K., Sommermann E., and Pettitt D.J. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size. Clin. Ther. 26 9 (2004) 1492-1497. http://dx.doi.org/10.1016/j.clinthera.2004.09.001
48. Seborg D.E., Edgar T.F., and Mellichamp D.A. Process Dynamics and Control. 2nd ed. (2004), John Wiley & Sons Ltd., New York
49. Åström K., and Wittenmark B. Adaptive Control. 2nd ed. (1995), Addison-Wesley, New York